Avanos Medical (AVNS) Inventory Average (2014 - 2026)

Avanos Medical (AVNS) has 13 years of Inventory Average data on file, last reported at $144.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 4.48% year-over-year to $144.6 million; the trailing twelve-month figure through Mar 2026 stood at $144.6 million (up 4.48% YoY), and the FY2025 full-year result was $143.4 million, down 5.03% from the prior year.
• Inventory Average slipped to $144.6 million in Q1 2026, from $149.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $181.3 million in Q3 2022 to a low of $138.4 million in Q1 2025.
• A 5-year average of $157.7 million and a median of $159.9 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average advanced 13.99% in 2022 and retreated 15.91% in 2023, its largest moves.
• Tracing AVNS's Inventory Average over 5 years: stood at $163.0 million in 2022, then retreated by 1.87% to $159.9 million in 2023, then decreased by 5.97% to $150.4 million in 2024, then slipped by 0.7% to $149.3 million in 2025, then slipped by 3.11% to $144.6 million in 2026.
• Business Quant data shows AVNS's Inventory Average at $144.6 million in Q1 2026, $149.3 million in Q4 2025, and $146.6 million in Q3 2025.